PDILT
gene geneOn this page
Also known as PDIA7
Summary
PDILT (protein disulfide isomerase like, testis expressed, HGNC:27338) is a protein-coding gene on chromosome 16p12.3, encoding Protein disulfide-isomerase-like protein of the testis (Q8N807). Probable redox-inactive chaperone involved in spermatogenesis.
This gene encodes a member of the disulfide isomerase (PDI) family of endoplasmic reticulum (ER) proteins that catalyze protein folding and thiol-disulfide interchange reactions. The encoded protein has has an N-terminal ER-signal sequence, two thioredoxin (TRX) domains with non-classical Ser-Lys-Gln-Ser and Ser-Lys-Lys-Cys motifs, respectively, two TRX-like domains, and a C-terminal ER-retention sequence. The protein lacks oxidoreductase activity in vitro and probably functions as a chaperone. This gene’s expression appears to be limited to the testis.
Source: NCBI Gene 204474 — RefSeq curated summary.
At a glance
- GWAS associations: 40
- Clinical variants (ClinVar): 129 total
- MANE Select transcript:
NM_174924
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27338 |
| Approved symbol | PDILT |
| Name | protein disulfide isomerase like, testis expressed |
| Location | 16p12.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | PDIA7 |
| Ensembl gene | ENSG00000169340 |
| Ensembl biotype | protein_coding |
| OMIM | 618588 |
| Entrez | 204474 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000302451, ENST00000575561
RefSeq mRNA: 1 — MANE Select: NM_174924
NM_174924
CCDS: CCDS10584
Canonical transcript exons
ENST00000302451 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001143197 | 20360568 | 20360657 |
| ENSE00001143206 | 20362404 | 20362582 |
| ENSE00001143224 | 20365420 | 20365540 |
| ENSE00001258511 | 20369492 | 20369689 |
| ENSE00001258516 | 20372802 | 20372927 |
| ENSE00001258528 | 20373012 | 20373122 |
| ENSE00001258536 | 20374822 | 20374959 |
| ENSE00001258543 | 20376068 | 20376201 |
| ENSE00001258562 | 20359175 | 20359567 |
| ENSE00001304204 | 20399099 | 20399307 |
| ENSE00001369072 | 20404496 | 20404737 |
| ENSE00003787367 | 20384645 | 20384851 |
Expression profiles
Bgee: expression breadth broad, 39 present calls, max score 81.97.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0193 / max 25.2608, expressed in 3 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 156689 | 0.0140 | 3 |
| 156688 | 0.0053 | 3 |
Top tissues by expression
194 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 81.97 | gold quality |
| right testis | UBERON:0004534 | 81.72 | gold quality |
| body of stomach | UBERON:0001161 | 81.17 | gold quality |
| testis | UBERON:0000473 | 79.22 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.70 | gold quality |
| stomach | UBERON:0000945 | 75.38 | gold quality |
| sperm | CL:0000019 | 72.18 | gold quality |
| cardia of stomach | UBERON:0001162 | 71.74 | gold quality |
| fundus of stomach | UBERON:0001160 | 70.90 | gold quality |
| buccal mucosa cell | CL:0002336 | 52.31 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 46.59 | silver quality |
| colonic epithelium | UBERON:0000397 | 45.80 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 45.77 | gold quality |
| synovial joint | UBERON:0002217 | 44.23 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 43.97 | gold quality |
| adult organism | UBERON:0007023 | 43.79 | gold quality |
| amniotic fluid | UBERON:0000173 | 43.78 | gold quality |
| duodenum | UBERON:0002114 | 43.75 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| medulla oblongata | UBERON:0001896 | 43.23 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 42.13 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 41.86 | gold quality |
| sural nerve | UBERON:0015488 | 41.76 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 41.72 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 41.69 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 41.54 | gold quality |
| vastus lateralis | UBERON:0001379 | 41.41 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 41.41 | gold quality |
| trigeminal ganglion | UBERON:0001675 | 41.39 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.43 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
7 targeting PDILT, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3162-3P | 100.00 | 65.37 | 363 |
| HSA-MIR-6783-3P | 99.89 | 67.92 | 2059 |
| HSA-MIR-1343-3P | 99.89 | 66.78 | 1815 |
| HSA-MIR-1299 | 99.77 | 71.24 | 2389 |
| HSA-MIR-875-3P | 99.63 | 69.47 | 2548 |
| HSA-MIR-5006-5P | 98.79 | 66.92 | 1246 |
| HSA-MIR-1322 | 97.98 | 68.96 | 625 |
Literature-anchored findings (GeneRIF, showing 3)
- The expression of PDILT, in addition to PDI in the testis, suggests that PDILT performs a specialized chaperone function in testicular cells. (PMID:15475357)
- Further studies of this recently discovered PDI member would help to understand the important role that PDILT plays in the differentiation and maturation of spermatozoids. (PMID:24662985)
- indings have identified the critical regions and conformational changes of PDILT that enable and control its activity. These results advance our understanding of the structural mechanisms involved in the chaperone activity of PDILT. (PMID:29203529)
Cross-species orthologs
12 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | pdia8 | ENSDARG00000033599 |
| danio_rerio | zgc:136472 | ENSDARG00000058445 |
| mus_musculus | Pdilt | ENSMUSG00000030968 |
| rattus_norvegicus | Pdilt | ENSRNOG00000015368 |
| drosophila_melanogaster | ERp60 | FBGN0033663 |
| drosophila_melanogaster | Tmx3 | FBGN0036579 |
| drosophila_melanogaster | Pdi | FBGN0286818 |
| caenorhabditis_elegans | WBGENE00003962 | |
| caenorhabditis_elegans | WBGENE00003963 | |
| caenorhabditis_elegans | pdi-3 | WBGENE00003964 |
| caenorhabditis_elegans | M04D5.1 | WBGENE00014807 |
| caenorhabditis_elegans | ZK973.11 | WBGENE00022836 |
Paralogs (13): ERP44 (ENSG00000023318), PDIA5 (ENSG00000065485), TMX4 (ENSG00000125827), ERP27 (ENSG00000139055), TMX1 (ENSG00000139921), PDIA6 (ENSG00000143870), TXNDC11 (ENSG00000153066), PDIA4 (ENSG00000155660), TMX3 (ENSG00000166479), PDIA3 (ENSG00000167004), PDIA2 (ENSG00000185615), P4HB (ENSG00000185624), TXNDC5 (ENSG00000239264)
Protein
Protein identifiers
Protein disulfide-isomerase-like protein of the testis — Q8N807 (reviewed: Q8N807)
All UniProt accessions (2): Q8N807, I3L1W7
UniProt curated annotations — full annotation on UniProt →
Function. Probable redox-inactive chaperone involved in spermatogenesis.
Subunit / interactions. Homodimer. The homodimer is not disulfide-linked. Interacts with ERO1A and CLGN.
Subcellular location. Endoplasmic reticulum.
Tissue specificity. Testis-specific.
Post-translational modifications. N-glycosylated.
Domain organisation. The thioredoxin domain lacks the conserved redox-active Cys at position 417 which is replaced by a Ser residue, suggesting that it lacks thioredoxin activity.
Similarity. Belongs to the protein disulfide isomerase family.
RefSeq proteins (1): NP_777584* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013766 | Thioredoxin_domain | Domain |
| IPR036249 | Thioredoxin-like_sf | Homologous_superfamily |
Pfam: PF00085, PF13848
UniProt features (66 total): helix 23, strand 18, sequence variant 7, turn 6, glycosylation site 5, mutagenesis site 2, signal peptide 1, chain 1, sequence conflict 1, domain 1, short sequence motif 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 4NWY | X-RAY DIFFRACTION | 2 |
| 5XF7 | X-RAY DIFFRACTION | 2.38 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N807-F1 | 85.18 | 0.75 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (5): 58, 128, 160, 340, 540
Mutagenesis-validated functional residues (2):
| Position | Phenotype |
|---|---|
| 135 | does not affect homodimerization; when associated with a-420. |
| 420 | does not affect homodimerization; when associated with a-135. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 38 (showing top):
GOBP_MALE_GAMETE_GENERATION, GOBP_PROTEIN_MATURATION, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_PROTEIN_FOLDING, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, chr16p12, GOMF_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY, GOMF_ISOMERASE_ACTIVITY, GOMF_PROTEIN_DISULFIDE_ISOMERASE_ACTIVITY, GOMF_PROTEIN_FOLDING_CHAPERONE, GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_DN, MIR875_3P, BDP1_TARGET_GENES, GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_UP, GOBP_SEXUAL_REPRODUCTION
GO Biological Process (5): protein folding (GO:0006457), spermatid development (GO:0007286), primordial germ cell migration (GO:0008354), spermatogenesis (GO:0007283), cell differentiation (GO:0030154)
GO Molecular Function (3): protein disulfide isomerase activity (GO:0003756), protein folding chaperone (GO:0044183), isomerase activity (GO:0016853)
GO Cellular Component (1): endoplasmic reticulum (GO:0005783)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular process | 1 |
| protein maturation | 1 |
| germ cell development | 1 |
| spermatid differentiation | 1 |
| gamete generation | 1 |
| cell migration | 1 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| intramolecular oxidoreductase activity, transposing S-S bonds | 1 |
| catalytic activity, acting on a protein | 1 |
| molecular_function | 1 |
| protein folding | 1 |
| catalytic activity | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
1091 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PDILT | CALR3 | Q96L12 | 697 |
| PDILT | PRSS37 | A4D1T9 | 671 |
| PDILT | CLGN | O14967 | 659 |
| PDILT | RNASE10 | Q5GAN6 | 628 |
| PDILT | MAGEB2 | O15479 | 608 |
| PDILT | TPST2 | O60704 | 598 |
| PDILT | UMOD | P07911 | 577 |
| PDILT | ADAM2 | P78326 | 574 |
| PDILT | PRSS55 | Q6UWB4 | 547 |
| PDILT | TEX101 | Q9BY14 | 545 |
| PDILT | TGM4 | P49221 | 512 |
| PDILT | CBLIF | P27352 | 499 |
| PDILT | TAF1D | Q9H5J8 | 476 |
| PDILT | LY6K | Q17RY6 | 474 |
| PDILT | DENND4A | Q7Z401 | 466 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PDILT | ITIH2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (3): SERPINB4 (Affinity Capture-MS), ITIH2 (Affinity Capture-MS), RABL6 (Affinity Capture-MS)
ESM2 similar proteins: A0A8M1N5Y4, A3KPF5, D7SFH9, O13811, O44342, P12865, P32474, P38658, P52588, Q0E0I1, Q0JD42, Q10057, Q17688, Q32L47, Q43116, Q498R3, Q4N4N8, Q53LQ0, Q54EN4, Q5FVM7, Q5R5L3, Q5RCM7, Q5WA72, Q5XI02, Q5ZKZ4, Q66GQ3, Q67IX6, Q69ST6, Q6AUC6, Q6NRT6, Q6P5E4, Q7XRB5, Q8IXB1, Q8N807, Q8VX13, Q8VZQ0, Q8W4J3, Q94F09, Q95LM0, Q96DN0
Diamond homologs: D3Z6P0, D4B2L8, O13704, O13811, O22263, O48773, O51890, P00275, P04785, P05307, P07237, P08003, P09102, P09103, P0A617, P0AGG4, P0AGG5, P0AGG6, P0AGG7, P10473, P11598, P13667, P21195, P23400, P27773, P29828, P30101, P34329, P38657, P38659, P38660, P38661, P46843, P52230, P52233, P52588, P52589, P54399, P55059, P73263
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
129 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 120 |
| Likely benign | 9 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1796 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:20359564:ACAG:A | acceptor_gain | 1.0000 |
| 16:20359565:CAG:C | acceptor_gain | 1.0000 |
| 16:20359565:CAGC:C | acceptor_gain | 1.0000 |
| 16:20359566:AG:A | acceptor_gain | 1.0000 |
| 16:20359567:GCT:G | acceptor_loss | 1.0000 |
| 16:20359568:C:CC | acceptor_gain | 1.0000 |
| 16:20360562:CCTTA:C | donor_loss | 1.0000 |
| 16:20360563:CTTA:C | donor_loss | 1.0000 |
| 16:20360564:TTA:T | donor_loss | 1.0000 |
| 16:20360565:TA:T | donor_loss | 1.0000 |
| 16:20360566:A:AC | donor_gain | 1.0000 |
| 16:20360566:A:AT | donor_loss | 1.0000 |
| 16:20360567:C:CC | donor_gain | 1.0000 |
| 16:20360567:CCT:C | donor_gain | 1.0000 |
| 16:20360654:CAGC:C | acceptor_gain | 1.0000 |
| 16:20360658:CTA:C | acceptor_loss | 1.0000 |
| 16:20360659:T:G | acceptor_loss | 1.0000 |
| 16:20362402:A:AC | donor_gain | 1.0000 |
| 16:20362403:C:CC | donor_gain | 1.0000 |
| 16:20373121:CCCT:C | acceptor_gain | 1.0000 |
| 16:20373122:CCTTG:C | acceptor_gain | 1.0000 |
| 16:20373124:T:C | acceptor_gain | 1.0000 |
| 16:20373124:T:TC | acceptor_gain | 1.0000 |
| 16:20399097:A:AC | donor_gain | 1.0000 |
| 16:20399098:C:CC | donor_gain | 1.0000 |
| 16:20399379:T:TA | donor_gain | 1.0000 |
| 16:20359563:AACAG:A | acceptor_gain | 0.9900 |
| 16:20359570:A:AC | acceptor_gain | 0.9900 |
| 16:20359570:A:C | acceptor_gain | 0.9900 |
| 16:20359577:C:CT | acceptor_gain | 0.9900 |
AlphaMissense
3895 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:20362492:G:T | A443D | 0.984 |
| 16:20362493:C:G | A443P | 0.984 |
| 16:20365428:A:T | V410E | 0.983 |
| 16:20384686:A:G | L123P | 0.978 |
| 16:20376172:A:G | W147R | 0.977 |
| 16:20376172:A:T | W147R | 0.977 |
| 16:20365482:A:T | L392H | 0.976 |
| 16:20369532:A:G | L359P | 0.975 |
| 16:20376162:C:G | R150P | 0.975 |
| 16:20376078:C:T | G178D | 0.973 |
| 16:20384758:C:T | G99D | 0.971 |
| 16:20399143:A:G | L53P | 0.969 |
| 16:20376079:C:G | G178R | 0.967 |
| 16:20374835:A:G | L223P | 0.966 |
| 16:20374894:A:C | F203L | 0.963 |
| 16:20374894:A:T | F203L | 0.963 |
| 16:20374896:A:G | F203L | 0.963 |
| 16:20362426:A:G | L465P | 0.960 |
| 16:20369601:A:T | V336D | 0.960 |
| 16:20374892:C:T | G204E | 0.960 |
| 16:20384683:A:G | F124S | 0.960 |
| 16:20399113:A:G | L63P | 0.959 |
| 16:20365431:A:G | F409S | 0.958 |
| 16:20365482:A:G | L392P | 0.958 |
| 16:20372881:A:G | L280P | 0.956 |
| 16:20399115:G:C | F62L | 0.956 |
| 16:20399115:G:T | F62L | 0.956 |
| 16:20399117:A:G | F62L | 0.956 |
| 16:20374838:A:T | V222D | 0.955 |
| 16:20399100:G:C | F67L | 0.955 |
dbSNP variants (sampled 300 via entrez): RS1000040458 (16:20380987 G>A), RS1000061660 (16:20361479 C>T), RS1000105930 (16:20394317 C>T), RS1000110471 (16:20360292 T>G), RS1000126809 (16:20366938 T>C), RS1000139628 (16:20398650 C>T), RS1000185965 (16:20370729 A>G,T), RS1000192736 (16:20361463 G>A,C), RS1000204527 (16:20383803 T>G), RS1000245301 (16:20360569 T>G), RS1000269416 (16:20389549 T>A), RS1000291124 (16:20366781 G>A,T), RS1000306053 (16:20383533 G>A,C), RS1000360532 (16:20377022 A>G), RS1000367519 (16:20378389 TCTC>T)
Disease associations
OMIM: gene MIM:618588 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
40 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000649_18 | Chronic kidney disease | 1.000000e-20 |
| GCST002376_1 | Urinary uromodulin levels | 6.000000e-27 |
| GCST002376_5 | Urinary uromodulin levels | 4.000000e-15 |
| GCST002720_1 | Kidney function decline traits | 2.000000e-17 |
| GCST002720_6 | Kidney function decline traits | 8.000000e-13 |
| GCST002720_7 | Kidney function decline traits | 9.000000e-08 |
| GCST002720_8 | Kidney function decline traits | 4.000000e-06 |
| GCST003790_11 | Glomerular filtration rate | 2.000000e-15 |
| GCST003790_5 | Glomerular filtration rate | 4.000000e-07 |
| GCST003790_6 | Glomerular filtration rate | 2.000000e-09 |
| GCST005984_40 | Glomerular filtration rate | 6.000000e-59 |
| GCST005985_56 | Creatinine levels | 2.000000e-53 |
| GCST005986_22 | Blood urea nitrogen levels | 7.000000e-29 |
| GCST006190_84 | Diastolic blood pressure x smoking status (ever vs never) interaction (2df test) | 6.000000e-08 |
| GCST006191_2 | Diastolic blood pressure x smoking status (ever vs never) interaction (1df test) | 2.000000e-08 |
| GCST007094_91 | Diastolic blood pressure | 2.000000e-09 |
| GCST007344_13 | Estimated glomerular filtration rate | 4.000000e-20 |
| GCST007344_16 | Estimated glomerular filtration rate | 3.000000e-83 |
| GCST007344_58 | Estimated glomerular filtration rate | 7.000000e-06 |
| GCST007344_84 | Estimated glomerular filtration rate | 3.000000e-09 |
| GCST007833_10 | Urolithiasis | 9.000000e-11 |
| GCST007877_17 | Creatinine levels | 2.000000e-16 |
| GCST007927_31 | Medication use (beta blocking agents) | 7.000000e-11 |
| GCST007928_3 | Medication use (diuretics) | 1.000000e-11 |
| GCST007930_102 | Medication use (agents acting on the renin-angiotensin system) | 7.000000e-17 |
| GCST008058_189 | Estimated glomerular filtration rate | 3.000000e-259 |
| GCST008059_102 | Estimated glomerular filtration rate | 1.000000e-213 |
| GCST008060_31 | Estimated glomerular filtration rate | 1.000000e-37 |
| GCST008062_8 | Blood urea nitrogen levels | 5.000000e-42 |
| GCST008064_26 | Chronic kidney disease | 7.000000e-86 |
EFO canonical traits (9, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005663 | urinary uromodulin measurement |
| EFO:0006829 | GFR change measurement |
| EFO:0006336 | diastolic blood pressure |
| EFO:0006527 | smoking status measurement |
| EFO:0009929 | Beta blocking agent use measurement |
| EFO:0009928 | Diuretic use measurement |
| EFO:0009931 | Agents acting on the renin-angiotensin system use measurement |
| EFO:0004340 | body mass index |
| EFO:0004531 | urate measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aflatoxin B2 | increases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): urolithiasis